CYANOCOBALMIN (Orobalin ®1mg tablet)

Clinical Indication

Higher strength cyanocobalmin oral product


Only to be used where there is malabsorption of Vitamin B12 in needle phobic patients, patients with mobility issues unable/ unsuitable to attend for injections or patients where injection is not tolerated preventing the use of hydroxycobalamin injections.

Date of classification

September 2022


Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.